Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL) Share Price

Price 0.125p on 25-09-2026 at 17:45:12
Change 0.00p 0%
Buy 0.13p
Sell 0.12p
Last Trade: Buy 200,000.00 at 0.13p
Day's Volume: 1,141,053
Last Close: 0.125p
Open: 0.125p
ISIN: GB00BLH13C52
Day's Range 0.125p - 0.125p
52wk Range: 0.125p - 0.625p
Market Capitalisation: £1.65m
VWAP: 0.128615p
Shares in Issue: 1.32b

ValiRx (VAL) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 200,000 0.13p Ordinary
15:40:27 - 25-Sep-26
Buy* 160,000 0.13p Ordinary
15:35:20 - 25-Sep-26
Buy* 100,000 0.13p Ordinary
15:01:02 - 25-Sep-26
Buy* 100,000 0.13p Ordinary
14:19:35 - 25-Sep-26
Buy* 339,884 0.13p Ordinary
13:57:08 - 25-Sep-26
Sell* 200,000 0.1221p Ordinary
09:50:23 - 25-Sep-26
Buy* 16,432 0.13p Ordinary
08:55:07 - 25-Sep-26
Buy* 3,876 0.13p SI Trade
08:55:07 - 25-Sep-26
Buy* 5,716 0.13p SI Trade
08:55:07 - 25-Sep-26
Buy* 8,738 0.13p SI Trade
08:55:07 - 25-Sep-26
See more ValiRx trades

ValiRx (VAL) Share Price History

Time period:
to
Date Open High Low Close Volume
25th Sep 2026 (Fri) 0.125 0.125 0.125 0.125 1,141,053
24th Sep 2026 (Thu) 0.13 0.13 0.125 0.125 20,128,568
23rd Sep 2026 (Wed) 0.135 0.135 0.13 0.13 4,096,960
22nd Sep 2026 (Tue) 0.135 0.135 0.135 0.135 1,002,958
21st Sep 2026 (Mon) 0.14 0.14 0.135 0.135 5,326,975
18th Sep 2026 (Fri) 0.14 0.14 0.14 0.14 1,838,972
17th Sep 2026 (Thu) 0.145 0.145 0.14 0.14 9,541,460
16th Sep 2026 (Wed) 0.145 0.145 0.145 0.145 701,976
15th Sep 2026 (Tue) 0.145 0.145 0.14 0.145 2,161,415
14th Sep 2026 (Mon) 0.145 0.145 0.145 0.145 11,488,627
11th Sep 2026 (Fri) 0.145 0.145 0.145 0.145 984,654
10th Sep 2026 (Thu) 0.145 0.145 0.145 0.145 1,686,659
9th Sep 2026 (Wed) 0.145 0.145 0.145 0.145 7,262,324
8th Sep 2026 (Tue) 0.14 0.145 0.14 0.145 7,029,583
7th Sep 2026 (Mon) 0.14 0.14 0.14 0.14 6,022,000
4th Sep 2026 (Fri) 0.14 0.14 0.14 0.14 1,327,913
3rd Sep 2026 (Thu) 0.14 0.14 0.14 0.14 20,032,317
2nd Sep 2026 (Wed) 0.145 0.145 0.14 0.14 2,786,069
1st Sep 2026 (Tue) 0.155 0.155 0.145 0.145 16,976,045
31st Aug 2026 (Mon) 0.155 0.155 0.155 0.155 0
28th Aug 2026 (Fri) 0.155 0.155 0.155 0.155 1,623,658
27th Aug 2026 (Thu) 0.155 0.155 0.155 0.155 729,861
See more ValiRx price history

ValiRx (VAL) Regulatory News

Date Source Headline
15th Sep 2026 7:00 am RNS Half-year Financial Report
10th Aug 2026 7:00 am RNS Cytolytix Patent Update
17th Jul 2026 12:25 pm RNS Result of AGM, Warrants & Directorate Change
22nd Jun 2026 7:00 am RNS Conclusion of Evaluation with University of Dundee
22nd Jun 2026 7:00 am RNS Final Results & Notice of AGM
2nd Jun 2026 7:00 am RNS Conclusion of Evaluation with Stingray
1st Jun 2026 7:00 am RNS ValiRx Exercises Option on Evaluation Asset
27th May 2026 7:00 am RNS Cytolytix Patent Granted
21st May 2026 7:00 am RNS Result of Oversubscribed WRAP Retail Offer
18th May 2026 7:00 am RNS WRAP Retail Offer for up to £150,000
See more ValiRx regulatory news

ValiRx (VAL) Share News

ValiRx subsidiary Cytolytix nears "significant" European patent win

10th Aug 2026 11:10

(Alliance News) - ValiRx PLC on Monday announced that the European Patent Office intends to grant a patent for "a key part" of majority-owned subsidiary Cytolytix Ltd's intellectual property portfolio. Read More

UK shareholder meetings calendar - next 7 days

10th Jul 2026 13:43

Read More

TRADING UPDATES: Maintel fundraising completes; ValiRx ends deal

22nd Jun 2026 14:22

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent

27th May 2026 20:36

ValiRx PLC - London-based life science company - Majority-owned subsidiary Cytolytix Ltd has its European patent "Nanoparticle for Anti-Cancer Peptides and Uses Thereof" granted. Notes the patent forms a "key part" of Cytolytix's intellectual property portfolio. Says the grant of the patent boosts Cytolytix's IP position, and affirms investment in the platform developed over the last few years. Adds that it also strengthens the firm's ability to attract external investment and expands licensing and partnership opportunities. Read More

TRADING UPDATES: IAG launches new buyback; Forgent settles legal case

15th May 2026 18:23

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

See more ValiRx news
FTSE 100 Latest
Value10,695.25
Change15.26

Login to your account

Forgot Password?

Not Registered